Loading...
Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study
BACKGROUND: Stimulation of vascular endothelial growth factor (VEGF) has been observed following transarterial chemoembolization (TACE) in hepatocellular cancer (HCC) and may contribute to tumor regrowth. This pilot study examined whether intravenous (IV) bevacizumab, a monoclonal antibody against V...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2012
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3292503/ https://ncbi.nlm.nih.gov/pubmed/22244160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-16 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|